These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39322401)
1. Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification. Chen Z; Li Q; Li Z; Hu G Clin Exp Pharmacol Physiol; 2024 Nov; 51(11):e13924. PubMed ID: 39322401 [TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762 [TBL] [Abstract][Full Text] [Related]
3. METTL14-Mediated m6A Modification of Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905 [TBL] [Abstract][Full Text] [Related]
4. METTL14-mediated lncRNA-FAS-AS1 promotes osteoarthritis progression by up-regulating ADAM8. Zhang Z; Mao H; Li F; Wang D; Liu Y Int J Rheum Dis; 2024 Sep; 27(9):e15323. PubMed ID: 39221886 [TBL] [Abstract][Full Text] [Related]
5. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of Lung Cancer]. Zhang Y; Wang Y; Liu M Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978 [TBL] [Abstract][Full Text] [Related]
6. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms. He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192 [TBL] [Abstract][Full Text] [Related]
7. M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer. Cai Y; Zheng H; Xu D; Xie J; Wang W; Liu Z; Zheng Z Pharmacology; 2024; 109(5):282-292. PubMed ID: 38744264 [TBL] [Abstract][Full Text] [Related]
8. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway. Xu D; Wang Z; Li F Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of the long noncoding RNA TRHDE-AS1 inhibits the progression of lung cancer via the miRNA-103/KLF4 axis. Zhuan B; Lu Y; Chen Q; Zhao X; Li P; Yuan Q; Yang Z J Cell Biochem; 2019 Oct; 120(10):17616-17624. PubMed ID: 31119790 [TBL] [Abstract][Full Text] [Related]
10. METTL14-mediated N6-methyladenosine modification of TCP1 mRNA promotes acute myeloid leukemia progression. Zhang M; Xie Z; Tan Y; Wu Y; Wang M; Zhang P; Yuan Y; Li J Cell Signal; 2024 Oct; 122():111304. PubMed ID: 39033992 [TBL] [Abstract][Full Text] [Related]
11. Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747. Wang J; Wang S; Yang H; Wang R; Shi K; Liu Y; Dou L; Yu H Cancer Sci; 2024 Sep; 115(9):2931-2946. PubMed ID: 38888105 [TBL] [Abstract][Full Text] [Related]
12. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1. Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676 [TBL] [Abstract][Full Text] [Related]
13. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner. Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429 [TBL] [Abstract][Full Text] [Related]
14. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression. Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801 [TBL] [Abstract][Full Text] [Related]
15. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer. Liu N; Zhang C; Zhang L Mol Biotechnol; 2024 Aug; 66(8):1883-1893. PubMed ID: 37477820 [TBL] [Abstract][Full Text] [Related]
16. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer. Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949 [TBL] [Abstract][Full Text] [Related]
17. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213 [TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA. Fu W; Liu L; Tong S Thorac Cancer; 2024 Jun; 15(17):1357-1368. PubMed ID: 38709912 [TBL] [Abstract][Full Text] [Related]
19. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
20. M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1. Luo XJ; Lu YX; Wang Y; Huang R; Liu J; Jin Y; Liu ZK; Liu ZX; Huang QT; Pu HY; Zeng ZL; Xu R; Zhao Q; Wu QN Cancer Lett; 2024 Aug; 598():217085. PubMed ID: 38964733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]